Business Description
2cureX AB
ISIN : SE0010468124
Compare
Compare
Traded in other countries / regions
2CUREX.Sweden2QE.Germany IPO Date
2017-11-24Description
2cureX AB is a biotech company. The company is engaged in improving treatment efficiency, mainly for cancer patients. It is involved in developing a product, namely IndiTreat, which is a technology for the treatment of colorectal, ovarian, and pancreatic cancers. The company's sub-products include IndiTreat Test, IndiTreat clinical programs, and IndiTreat Therapy Design.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.4 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -12.48 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -50.7 | |||||
| 3-Year EPS without NRI Growth Rate | -50.8 | |||||
| 3-Year FCF Growth Rate | -25.9 | |||||
| 3-Year Book Growth Rate | -44.3 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 46.15 | |||||
| 9-Day RSI | 45.34 | |||||
| 14-Day RSI | 45.7 | |||||
| 6-1 Month Momentum % | 54.84 | |||||
| 12-1 Month Momentum % | -78.18 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.51 | |||||
| Quick Ratio | 1.51 | |||||
| Cash Ratio | 0.73 | |||||
| Days Sales Outstanding | 4720.96 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -5.8 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -21774.25 | |||||
| Net Margin % | -19471.26 | |||||
| FCF Margin % | -18695.81 | |||||
| ROE % | -216.9 | |||||
| ROA % | -174.41 | |||||
| ROIC % | -767.61 | |||||
| ROC (Joel Greenblatt) % | -4455.17 | |||||
| ROCE % | -236.79 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 0.55 | |||||
| PS Ratio | 47 | |||||
| PB Ratio | 2.97 | |||||
| Price-to-Tangible-Book | 2.94 | |||||
| EV-to-EBIT | -0.13 | |||||
| EV-to-Forward-EBIT | -7.96 | |||||
| EV-to-EBITDA | -0.13 | |||||
| EV-to-Revenue | 30.81 | |||||
| EV-to-Forward-Revenue | 11.06 | |||||
| EV-to-FCF | -0.23 | |||||
| Price-to-Net-Current-Asset-Value | 3.92 | |||||
| Earnings Yield (Greenblatt) % | -705.39 | |||||
| FCF Yield % | -377.4 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
2cureX AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 0.167 | ||
| EPS (TTM) (kr) | -1.85 | ||
| Beta | 0.42 | ||
| Volatility % | 110.05 | ||
| 14-Day RSI | 45.7 | ||
| 14-Day ATR (kr) | 0.063751 | ||
| 20-Day SMA (kr) | 0.49975 | ||
| 12-1 Month Momentum % | -78.18 | ||
| 52-Week Range (kr) | 0.203 - 2.8 | ||
| Shares Outstanding (Mil) | 17.6 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
2cureX AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
2cureX AB Stock Events
| Event | Date | Price(kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
2cureX AB Frequently Asked Questions
What is 2cureX AB(OSTO:2CUREX)'s stock price today?
The current price of OSTO:2CUREX is kr0.47. The 52 week high of OSTO:2CUREX is kr2.80 and 52 week low is kr0.20.
When is next earnings date of 2cureX AB(OSTO:2CUREX)?
The next earnings date of 2cureX AB(OSTO:2CUREX) is 2025-02-27.
Does 2cureX AB(OSTO:2CUREX) pay dividends? If so, how much?
2cureX AB(OSTO:2CUREX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers